MiCo BioMed (214610) Stock Overview

MiCo BioMed Co., Ltd. provides on-site diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) System, a device which include, membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; and LabChip, sample tube, and pre-filtering column. It also provides biological chemistry products, including VERI-Q Multi, a cholesterol diagnostic product; VERI-Q RED, a hemoglobin monitoring system; Healthy- Q Life, a cholesterol monitoring system; Healthy- Q Multi, a multifunctional monitoring system; and Healthy- Q Balance Pro. In addition, the company offers immunoassay diagnostics products. The company was formerly known as MiCo NanoBioSys Co., Ltd. and changed its name to MiCo BioMed Co., Ltd. in March 2018. MiCo BioMed Co., Ltd. was founded in 2009 and is headquartered in Seongnam, South Korea.